Oct 29, 7:10 AM ET
Axalta reported third-quarter 2026 net sales of $1.3 billion, up 2% year over year, while net income fell $15 million to $95 million and diluted EPS dropped to $0.44 from $0.51. The company cited $14 million more in merger and acquisition-related expenses, tied to its proposed combination with AkzoNobel, and lower volumes in Performance Coatings. Shareholders also received fourth-quarter and full-year 2026 outlook figures, including full-year Adjusted EBITDA of $1,100 million to $1,110 million.
- Q3 2026 net sales were $1.3 billion, up 2%; Adjusted EBITDA was $282 million, down 4%, with a 21.5% margin
- Diluted EPS was $0.44 versus $0.51 a year earlier; Adjusted Diluted EPS was $0.63, down 6%
- Mobility Coatings posted record quarterly net sales of $493 million; Performance Coatings Adjusted EBITDA fell to $188 million from $211 million
- Outlook: Q4 2026 Adjusted EBITDA of $254 million to $264 million; full-year 2026 Adjusted EBITDA of $1,100 million to $1,110 million and Adjusted Diluted EPS of about $2.45
Read the filing on SEC.gov ↗
Jul 28, 6:02 AM ET
Axalta reported second-quarter 2026 net sales of $1.35 billion, up 3% year over year, and a record Adjusted EBITDA of $305 million. GAAP net income fell to $89 million from $110 million and diluted EPS to $0.41 from $0.50, mainly due to $31 million in higher merger and acquisition costs. The company's full-year 2026 outlook calls for Adjusted Diluted EPS of $2.55 to $2.70, and shareholders are asked to attend a Special General Meeting on August 5 on the merger of equals with AkzoNobel.
- Net sales of $1.35 billion, up 3% year over year; Adjusted EBITDA of $305 million, a quarterly record, up 5%
- Diluted EPS of $0.41 versus $0.50 a year earlier; net income of $89 million versus $110 million, reflecting an incremental $31 million in merger and acquisition costs
- Adjusted Diluted EPS of $0.72, a record quarter and up 13% year over year
- Full-year 2026 outlook: Adjusted EBITDA $1,140 million to $1,170 million; Adjusted Diluted EPS $2.55 to $2.70; Special General Meeting on August 5
Read the filing on SEC.gov ↗
Jul 23, 9:04 AM ET
On July 23, 2026, Axalta entered Amendment No. 2 to its merger agreement with AkzoNobel, changing governance terms for the combined company. The amendment sets annual re-election of all MergeCo directors after an initial three-year period and a two-thirds non-executive director approval threshold for specified matters during that period. The companies said the changes leave the August 5, 2026 AkzoNobel EGM and Axalta SGM on schedule, so shareholder votes are not affected by the amendment.
- Annual re-election of all MergeCo directors after the initial three-year period; the press release says this was previously contemplated after five years.
- Two-thirds non-executive director approval threshold during the initial three years for director appointments and dismissals, CEO, Deputy CEO and CFO changes, Chair and Vice Chair titles, and remuneration policy amendments; the press releas
- AkzoNobel EGM and Axalta SGM planned for August 5, 2026 are proceeding with existing agenda items unaffected.
Read the filing on SEC.gov ↗
May 28, 6:16 AM ET
On May 27, 2026, Axalta entered into Amendment No. 1 to its merger agreement with AkzoNobel, which changes how the combination would be structured. The amendment adds a second wholly owned AkzoNobel subsidiary and a second merger in which Axalta would merge into that subsidiary after the first merger, and it sets out how independent directors would join the combined company's board. The company says these changes are meant to optimize tax integration but do not change the tax consequences for Axalta shareholders.
- Amendment No. 1 to the Merger Agreement was signed May 27, 2026, amending the original agreement dated November 18, 2025.
- The amendment adds AkzoNobel Sub 2 and a Second Merger in which Axalta's surviving company merges into it, becoming a direct wholly owned AkzoNobel subsidiary.
- Axalta says the changes do not alter the tax consequences of the transaction for Axalta shareholders.
- A preliminary proxy statement/prospectus was filed with the SEC on May 27, 2026; a definitive version is to be mailed to shareholders when available.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
